Lee's Pharmaceutical Holdings Limited
LPCUF
$0.185
-$0.0091-4.69%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 179.44M | 166.34M | 153.35M | 143.92M | 134.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 179.44M | 166.34M | 153.35M | 143.92M | 134.51M |
| Cost of Revenue | 82.88M | 78.61M | 74.39M | 69.23M | 64.09M |
| Gross Profit | 96.56M | 87.73M | 78.97M | 74.69M | 70.42M |
| SG&A Expenses | 76.44M | 71.82M | 67.26M | 65.19M | 63.13M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -7.74M | -7.78M | -7.83M | -8.75M | -9.67M |
| Total Operating Expenses | 162.32M | 153.27M | 144.31M | 137.10M | 129.91M |
| Operating Income | 17.12M | 13.07M | 9.04M | 6.82M | 4.60M |
| Income Before Tax | 12.57M | 10.42M | 8.28M | 6.10M | 3.93M |
| Income Tax Expenses | 3.79M | 2.58M | 1.38M | 1.38M | 1.38M |
| Earnings from Continuing Operations | 8.78 | 7.84 | 6.89 | 4.72 | 2.54 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 3.14M | 2.15M | 1.17M | 378.00K | -414.20K |
| Net Income | 11.92M | 9.99M | 8.06M | 5.10M | 2.13M |
| EBIT | 17.12M | 13.07M | 9.04M | 6.82M | 4.60M |
| EBITDA | 28.21M | 24.20M | 20.20M | 18.43M | 16.67M |
| EPS Basic | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 |
| Normalized Basic EPS | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 |
| EPS Diluted | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 |
| Normalized Diluted EPS | 0.02 | 0.02 | 0.01 | 0.01 | 0.00 |
| Average Basic Shares Outstanding | 2.36B | 2.36B | 2.36B | 2.36B | 2.36B |
| Average Diluted Shares Outstanding | 2.36B | 2.36B | 2.36B | 2.36B | 2.36B |
| Dividend Per Share | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payout Ratio | 19.00% | 18.11% | 16.81% | 26.57% | 63.53% |